Back to Search
JOSE FERRERO, M.D
M.D
Physical Medicine & Rehabilitation Physician
NPI: 1508829391Individual
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
11455(PR)0101262365(VA)
Research & Publications (20)
[Hormonoresistant metastatic prostate cancer: analysis of two phase III clinical studies].
PMID 15932803·Bull Cancer·2005
6-review
[Cardiac tolerance of the combination paclitaxel-anthracyclines in the context of the management of cancer of the breast].
PMID 12801824·Bull Cancer·2003
6-review
The raltitrexed-vinorelbine combination: a phase I pharmacokinetic and pharmacodynamic trial in advanced breast cancer.
PMID 12451472·Cancer Chemother Pharmacol·2002
3-trial
Docetaxel-based chemotherapy in elderly patients (age 75 and older) with castration-resistant prostate cancer.
PMID 18706755·Eur Urol·2009
8-other
Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group.
PMID 19190632·Br J Cancer·2009
3-trial
The relative role of refractoriness and source-sink relationship in reentry generation during simulated acute ischemia.
PMID 19495982·Ann Biomed Eng·2009
7-preclinical
[CyberKnife and neoadjuvant chemotherapy for breast tumors: preliminary results].
PMID 19201239·Cancer Radiother·2009
3-trial
Robotic stereotactic radioablation concomitant with neo-adjuvant chemotherapy for breast tumors.
PMID 19386428·Int J Radiat Oncol Biol Phys·2009
3-trial
Characterization of cobalt pigments found in traditional Valencian ceramics by means of laser ablation-inductively coupled plasma mass spectrometry and portable X-ray fluorescence spectrometry.
PMID 18371780·Talanta·2008
8-other
Vibrational energy transfer between I2(B (3)Pi(0u)+, nu' = 21) and He at very low temperatures: impulsive versus complex formation mechanisms assisted by tunneling through the centrifugal barrier.
PMID 19045143·J Chem Phys·2008
8-other
Preclinical pharmacokinetics of a HepDirect prodrug of a novel phosphonate-containing thyroid hormone receptor agonist.
PMID 18703645·Drug Metab Dispos·2008
4-observational
[Antidepressants in oncology: issues and clinical perspectives].
PMID 19036683·Bull Cancer·2008
8-other
A grid computing-based approach for the acceleration of simulations in cardiology.
PMID 18348943·IEEE Trans Inf Technol Biomed·2008
8-other
Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancer.
PMID 17593391·J Cancer Res Clin Oncol·2008
7-preclinical
Purification, crystallization and preliminary crystallographic study of a recombinant plant aminoaldehyde dehydrogenase from Pisum sativum.
PMID 18259056·Acta Crystallogr Sect F Struct Biol Cryst Commun·2008
8-other
Haematological evaluation of weekly therapy with topotecan for the treatment of recurrent ovarian cancer resistant to platinum-based therapy.
PMID 18418010·Oncology·2007
8-other
Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patients.
PMID 17846024·Ann Oncol·2007
4-observational
Accounting for the dependence of P(E',E) on the maximum impact parameter in classical trajectory calculations: application to the H2O-H2O collisional relaxation.
PMID 17949147·J Chem Phys·2007
8-other
Chemiluminescent reaction of Ba(3P) with N2O at hyperthermal collision energies: rotational alignment of the BaO(A 1Sigma+) product.
PMID 17705598·J Chem Phys·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via 10340 Spotsylvania Ave Ste 101 · 2 locations total
- Address
- 10340 SPOTSYLVANIA AVE STE 101
FREDERICKSBURG, VA 22408 - Phone
- (540) 374-3164
Quick Facts
- NPI
- 1508829391
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile